期刊文献+

存活素、caspase-3在不对称良性前列腺增生中的表达及意义 被引量:2

Expression patterns of survivin and caspase-3 in dissymmetric enlarged
原文传递
导出
摘要 目的观察存活素、caspase-3在不对称BPH中的表达情况,探讨凋亡在BPH发病机制中的作用。方法采用自身对照设计,应用PV二步法免疫组织化学方法检测25例不对称BPH增生明显叶与不明显叶中存活素、caspase-3的表达情况。结果增生明显叶组存活素蛋白阳性率为(22.08±16.33)%,不明显叶组为(7.64±5.45)%,2组间差异有统计学意义(t=4.817,P〈0.01)。增生明显叶组caspase-3蛋白阳性率为(33.12±21.01)%,不明显叶组为(51.52±27.27)%,2组间差异有统计学意义(t=-5.770,P〈0.01)。两者在增生明显叶组表达呈负相关(r=-0.474,P〈0.05);而在增生不明显叶组表达无相关性(r=-0.313,P〉0.05)。结论存活素、caspase-3引起腺体的不同凋亡状态与前列腺增生程度密切相关,提示凋亡机制在BPH的发生与发展中发挥重要作用。 Objective To compare the different expression patterns of survivin and caspase-3 between the larger part and the smaller part of the dissymmetric enlarged prostates in BPH patients, and to clarify the role of apoptosis in BPH etiology. Methods BPH tissues from 25 patients were embedded in paraffin. The specimens constituted of two prostate parts from each patient. One part was from the larger enlarged gland and the other was from the smaller enlarged counterpart. 50 paraffin blocks were cut into sections and stained with survivin and caspase-3 polyclonal antibodies against human. All the data was analyzed by SPSS13.0 software. Results Survivin immunoreactivity was localized in prostatic cell nuclei. Survivin expression in larger enlarged parts (22.08± 16.33)% was significantly higher than the smaller parts (7.64±5.45)% (P〈0.01). Positive nuclear or cytoplasm staining was also observed in the Caspase-3 immunoreactivity. Caspase-3 expression was higher in smaller enlarged parts (51. 52 ± 27. 27%) than in larger enlarged parts (33. 12 ± 21. 01%) (P〈 0.01). Survivin expression in larger part of the enlarged prostates was inversely correlated with caspase-3 expression (r=- 0. 474, P〈0.05). However, in smaller part of the enlarged prostates, the expression of the two factors had no relation (r=-0. 313,P〉0.05). Conclusions Survivin and caspase-3 expression patterns are different in the two parts of the dissymmetric enlarged prostates. These different patterns indicate apoptosis playing an important role in BPH development.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2009年第7期484-486,共3页 Chinese Journal of Urology
关键词 良性前列腺增生 凋亡 存活素 CASPASE-3 Benign prostatic hyperplasia (BPH) Apoptosis Survivin Caspase-3
  • 相关文献

参考文献9

  • 1Ambrosini G,Adida C,Ahieri DC.A novel anti-apoptosis gene,survivin,expressed in cancer and lymphoma.Nat Med,1997,3,917-921.
  • 2Enari M,Sakahira H,Yokoyama H,et al.A caspase-activated DNase that degrades DNA during apoptosis,and its inhibitor ICAD.Nature,1998,391:43-50.
  • 3方文杰,江鉴平,金能成,蒋方,毕满华.前列腺不对称增生(附68例报告)[J].安徽医学,2005,26(3):212-213. 被引量:2
  • 4彭轼平.良性前列腺增生概论.吴阶平,顾方六,郭应禄,主编.吴阶平泌尿外科学.下册.山东:科学技术出版社,2004.1127-1150.
  • 5Shariat SF,Ashfaq R,Roehrborn CG,et al.Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia.J Urol,2005,174:2046-2050.
  • 6Bozec A,Ruffion A,Decaussin M,et al.Activation of caspases-3,-6,and -9 during finasteride treatment of benign prostatic hyperplasia.J Clin Endocrinol Metab,2005,90:17-25.
  • 7O'Neill AJ,Boran SA,O'Keane C,et al.Caspase 3 expression in benign prostatic hyperplasia and prostate carcinoma.Prostate,2001,47,183-188.
  • 8Sohn JH,Kim DH,Choi NG,et al.Caspase-3/CPP32 immunoreactivity and its correlation with frequency of apoptotic bodies in human prostatic carcinomas and benign nodular hyperplasias.Histopathology,2000,37:555-560.
  • 9邓春华,丘少鹏,陈辉熔,郑克立,梅骅,刘建中.Caspase-3在前列腺组织中的表达和意义[J].中国男科学杂志,2003,17(4):224-228. 被引量:14

二级参考文献15

  • 1张杰秀,华立新,吴宏飞,眭元庚,张炜,钱立新,王增军.前列腺增生术后发生前列腺癌12例报告[J].临床泌尿外科杂志,2004,19(10):590-591. 被引量:5
  • 2俞建军,徐月敏.前列腺增生术后复发的相关因素探讨[J].临床泌尿外科杂志,2004,19(10):600-601. 被引量:8
  • 3Sohn JH, Kim DH, Choi N3, et al. Caspase-3/CPP32 immunoreactivity and its correlation with frequency of apoptotic bodies in human prostatic carcinomas and benign nodular hyperplasias. Histopathology 2000;37(6) :555.
  • 4Winter RN,Kramer A,Borkowski A, et al. I.ass of caspase-1 and caspase-3 protein expression in human prostate canoer.Cancer Res 2001 ;61(3) : 1227.
  • 5Virkajarvi N, Paallp P, Soini Y. Apoptotic index and apoptosis influencing proteins bcl-2 ,mcl-1 ,bax and caspase 3,6 and 8 in pancreatic carcinoma. Histopathology 1998;33 : 432.
  • 6Hosi T, Sasano GI,Kato K, et al. Immunohistochemistry of caspase-3/CPP32 in human stomach and its correlation with cell proliferation and apoptosis. Anticancer Res 1998;18 : 4347.
  • 7Claus S, Berges R, Senge T, et al. Cell kinetic in epithelium and stroma of benign prostatic hyperplasia. J Urol 1997; 158:217.
  • 8Collmbel M, Vacherot, F, Gil Diez S, et al. Zonal variation of apoptosis and proliferation in the normal prostate and in benign prostatic hyperplasia. Brit J Urol 1998 ; 82 : 280.
  • 9Kyprianou N, Tu H, Jacobs SC. Aoptotic versus proliferative activities in human benign prostatic hyperplasia. Human Pathol 1996;27:668.
  • 10Ronan NT, Coffey R, William G, et al. Signaling for the caspases: their role in prostate cell apoptosis. J Urol 2001;165(1) :5.

共引文献20

同被引文献9

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部